CERT Certara

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the 43rd Annual J.P. Morgan Healthcare Conference.

Company management will present at 5:15PM PT on Wednesday, January 15th, 2025.

A live webcast of the event will be available on Certara’s investor relations website at and will be available for replay for at least 30 days thereafter.

About Certara

Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.

Investor Relations Contact:

David Deuchler

Gilmartin Group

Media Contact:

Alyssa Horowitz



EN
02/01/2025

Underlying

CERTCertara

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Certara

 PRESS RELEASE
Free
CERT CERTARA

Certara to Report Fourth Quarter and Full Year 2024 Financial Results ...

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening to the conference call are required to . ...

January 29, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 47.78
ZBH ZIMMER BIOMET H...
TWI Titan Internati... ... (+49)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

ZBH ZIMMER BIOMET HOLDINGS INC.
TWI TITAN INTERNATIONAL INC.
TRIP TRIPADVISOR INC.
TITN TITAN MACHINERY
SLP SIMULATIONS PLUS
RYI RYERSON HOLDING CORPORATION
QCOM QUALCOMM INC
PCRX PACIRA BIOSCIENCES INC.
MOS MOSAIC COMPANY
J7Z JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
IVZ INVESCO LTD.
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
DLTR DOLLAR TREE INC.
DDD 3D SYSTEMS CORPORATION
CERS CERUS CORP.
AVD AMERICAN VANGUARD
ANIP ANI PHARMACEUTICALS INC.
AGCO AGCO CORPORATION
UPS UNITED PARCEL SERVICE INC. CLASS B
OSTK OVERSTOCK.COM INC.
GDEN GOLDEN ENTERTAINMENT
FRX_CN FENNEC PHARMACEUTICALS
ODEL.N0000 ODEL PLC
BRKS BROOKS AUTOMATION INC.
CCV COUNTERPATH
TDC TERADATA CORPORATION
BHF BRIGHTHOUSE FINANCIAL INC.
ZS ZSCALER INC.
TENB TENABLE HOLDINGS
SIBN SI-BONE
PINS PINTEREST INC. CLASS A
VIAC VIACOMCBS INC. CLASS B
ORIC ORIC PHARMACEUTICALS
THRY THRYV HOLDINGS
CERT CERTARA
ONTF ON24
SMTI SANARA MEDTECH
SDGR SCHRODINGER
COUR COURSERA INC
BBWI BATH & BODY WORKS INC
DH DEFINITIVE HEALTHCARE CORP
VERV VERVE THERAPEUTICS INC
PTLO PORTILLOS INC
DCGO DOCGO INC
EHAB ENHABIT INC
SVV SAVERS VALUE VILLAGE INC
QIPT PATIENT HOME MONITORING CORP
HUM HAMILTON U.S. MID-CAP FINANCIALS ETF
CXM SPRINKLR INC
01/29/25 January 29, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 47.78
BA BOEING COMPANY ...
ZBH ZIMMER BIOMET H... ... (+34)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

BA BOEING COMPANY (THE)
ZBH ZIMMER BIOMET HOLDINGS INC.
SLB.N SCHLUMBERGER NV
CNHI CNH INDUSTRIAL NV
WBA WALGREENS BOOTS ALLIANCE INC
ULTA ULTA BEAUTY INC
SLP SIMULATIONS PLUS
PCRX PACIRA BIOSCIENCES INC.
PBF PBF ENERGY INC. CLASS A
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
HXL HEXCEL CORPORATION
DAN DANA INCORPORATED
CVI CVR ENERGY INC.
AGCO AGCO CORPORATION
ACAD ACADIA PHARMACEUTICALS INC.
ALV ALLIANZ SE
MUR MURPHY OIL CORPORATION
BRKS BROOKS AUTOMATION INC.
HP HELMERICH & PAYNE INC.
PTEN PATTERSON-UTI ENERGY INC.
VLO VALERO ENERGY CORPORATION
HI HILLENBRAND INC.
INGR-R-A INGRA D.D.
EYE NATIONAL VISION HOLDINGS
CPRI CAPRI HOLDINGS LIMITED
TW TRADEWEB MARKETS INC. CLASS A
REEMF RARE ELEMENT RESOURCES
NVST ENVISTA HOLDINGS
PGNY PROGYNY
CERT CERTARA
VAL VALARIS LTD
BBWI BATH & BODY WORKS INC
CIVI CIVITAS RESOURCES INC
INVX INNOVEX INTERNATIONAL INC
01/24/25 January 24, 2025 1 EN
 PRESS RELEASE
Free
CERT CERTARA

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financia...

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 millionConfirms Adjusted EBITDA within Guidance Range of $120 million to $124 million RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced revenue and bookings for the fourth quarter and full year of fiscal year 2024 based on a preliminary review of fourth quarter results. Preliminary financials for the fourth quarter of 2024 are expected to be as follow...

January 15, 2025 1 EN
 PRESS RELEASE
Free
CERT CERTARA

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Confe...

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Company management will present at 5:15PM PT on Wednesday, January 15th, 2025. A live webcast of the event will be available on Certara’s investor relations website at and will be available for replay for at least 30 days thereafter. About CertaraCertara accelerates medicine...

January 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch